Liver Resection vs Transplant: When Is Each Better?

Resection is better when the liver behind the tumour is healthy enough to function after part of it is removed. Transplant is better when the liver itself is diseased, usually cirrhotic, and the tumour fits within the size and number criteria that make recurrence after a donated organ unlikely. Both can cure liver cancer. The tumour is rarely the only deciding factor. The liver’s own health decides as much as the cancer does.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “Liver resection and transplant are not competing options. They’re answers to different clinical questions. Resection asks whether the tumour can be removed with enough healthy liver left behind. Transplant asks whether the cancer fits within criteria where recurrence after a donated organ is unlikely enough to justify using it. The tumour board weighs both before recommending either.”

Good liver function behind the tumour changes everything.

• Healthy underlying liver: Child-Pugh A function, no significant portal hypertension. The remnant liver regenerates. Patients with cirrhosis are at much higher risk for post-resection failure. That’s the key dividing line between who resects and who doesn’t.
• Resectable tumour anatomy: Single or limited tumours not hugging major vessels or bile ducts. Clear margins needed. At least 20 to 30 percent functional liver volume must remain after the resection.
• No donor, no waiting: Resection is available now. No list. No matching. No lifelong immunosuppression afterwards. For patients with good liver function and resectable disease, that’s a real practical advantage.
• Beyond Milan but still confined: Tumours too large for transplant criteria but still within the liver can be resected when function holds up. These patients don’t have a transplant path without downstaging first.

For patients whose liver cancer is removed using minimally invasive approaches, robotic cancer surgery brings precision hepatectomy with lower blood loss and faster recovery than open liver resection.

• Milan criteria define transplant eligibility: Single tumour under 5 cm, or up to three tumours none exceeding 3 cm, no vascular invasion, no spread outside the liver. Within these criteria 5-year post-transplant survival exceeds 70 percent.
• Recurrence after resection in cirrhotic liver: Runs 50 to 70 percent at 5 years. Not because surgery failed. The remaining diseased liver keeps generating new tumours. Transplant removes that substrate entirely.
• Downstaging for transplant: Patients outside Milan criteria can sometimes be brought inside using TACE or ablation before listing. Bridge therapy. Standard at experienced centres now, not a workaround.
• Living donor reality in India: Deceased donor availability is very limited here. Living donor liver transplant from a family member is the primary transplant pathway at most Indian centres. That changes the waiting time equation completely from what patients read about Western transplant programmes.

For patients who want to understand whether liver cancer is curable at their current stage, our blog on liver cancer curable explains what that means across stages and treatment types.

Dr. Sandeep Nayak has spent 24 years in surgical oncology. He holds DNB qualifications in Surgical Oncology and General Surgery, plus a fellowship in Laparoscopic and Robotic Onco Surgery. He performs robotic and laparoscopic hepatectomy for liver cancer resection, works closely with the liver transplant and hepatology teams for transplant assessment cases, and presents every liver cancer case to the tumour board so both resection and transplant are formally evaluated before any recommendation is made.

That joint evaluation at the first consultation, rather than being moved between departments after initial workup, is what prevents patients being funnelled into one pathway when the other might serve them better. Call +91 8104310753 to book your consultation.

Disclaimer: This blog is for informational purposes only and is not a substitute for professional medical advice.